nifedipine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One of the most common signs of breast tumors is the presence of small deposits of calcium, known as microcalcifications." | 1.56 | Calcium signaling affects migration and proliferation differently in individual cancer cells due to nifedipine treatment. ( Babula, P; Chovancova, B; Durinikova, E; Hudecova, S; Krizanova, O; Liskova, V; Matuskova, M; Miklikova, S; Novakova, M; Penesova, A; Sevcikova, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chovancova, B | 1 |
| Liskova, V | 1 |
| Miklikova, S | 1 |
| Hudecova, S | 1 |
| Babula, P | 1 |
| Penesova, A | 1 |
| Sevcikova, A | 1 |
| Durinikova, E | 1 |
| Novakova, M | 1 |
| Matuskova, M | 1 |
| Krizanova, O | 1 |
1 other study available for nifedipine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Calcium signaling affects migration and proliferation differently in individual cancer cells due to nifedipine treatment.
Topics: Antineoplastic Agents, Immunological; Apoptosis; Breast Neoplasms; Calcium Channel Blockers; Calcium | 2020 |